Skip to content

Do people with Down syndrome get Alzheimer's and why?

3 min read

The lifetime risk of developing Alzheimer's disease by age 65 in people with Down syndrome is significantly higher and earlier than in the general population. The direct link is the extra copy of chromosome 21, which causes an overproduction of the protein responsible for forming brain plaques characteristic of Alzheimer's disease.

Quick Summary

Adults with Down syndrome face a substantially higher risk and earlier onset of Alzheimer's disease than the general population. This is caused by an extra copy of the APP gene on chromosome 21, leading to an excess buildup of amyloid plaques and tau tangles in the brain starting around age 40.

Key Points

  • Genetic Link to Trisomy 21: The high risk of Alzheimer's in Down syndrome is directly caused by an extra copy of chromosome 21, which contains the APP gene responsible for producing beta-amyloid.

  • Early Brain Pathology: By age 40, most individuals with Down syndrome have significant amyloid plaques and tau tangles in their brains, the hallmarks of Alzheimer's.

  • Earlier Symptom Onset: While brain changes start early, clinical symptoms typically appear around age 53-55, decades sooner than late-onset Alzheimer's in the general population.

  • Altered Symptom Presentation: Early signs of Alzheimer's in people with Down syndrome often include behavioral and personality changes, or a loss of skills, which can differ from the initial memory loss seen in the general population.

  • Diagnosis is Complex: Diagnosis requires thorough, longitudinal tracking of a person's function with input from caregivers, as standard cognitive tests may not be effective.

  • Lifestyle Can Help: Maintaining a healthy diet, staying physically active, promoting mental health, and ensuring good sleep hygiene are all recommended strategies to potentially mitigate risk.

  • Hope Through Research: Ongoing research focuses on developing blood tests, imaging techniques, and targeted therapies, leveraging the predictable progression in Down syndrome to find new treatments for everyone with Alzheimer's disease.

In This Article

Yes, individuals with Down syndrome have a much higher likelihood of developing Alzheimer's disease, and it often occurs at a younger age than in the general population. The reason is genetic, stemming directly from the extra genetic material that defines Down syndrome, also known as Trisomy 21.

The Genetic Cause: Chromosome 21 and the APP Gene

Down syndrome is caused by having an extra copy of chromosome 21. This extra chromosome carries an extra copy of the Amyloid Precursor Protein (APP) gene. The APP gene produces a protein that, when broken down, creates beta-amyloid. The extra copy of the APP gene leads to an overproduction of the APP protein, causing an accelerated buildup of beta-amyloid plaques in the brain, a hallmark of Alzheimer's disease. By age 40, nearly all people with Down syndrome show significant levels of amyloid plaques and tau tangles in their brains.

Why symptoms appear later than pathology

Although the plaques and tangles begin to form early, the clinical symptoms of dementia typically do not manifest until much later. The average age of diagnosis for a person with Down syndrome and Alzheimer's is around 53 to 55 years old. This delay provides a crucial opportunity for research into preventative treatments.

The course and symptoms of Alzheimer's in Down syndrome

The progression of Alzheimer's in people with Down syndrome can differ from the general population. Due to pre-existing intellectual disabilities, early signs of cognitive decline can be subtle. Initial symptoms often include changes in personality, behavior, and function, such as reduced social interest, increased anxiety, or a decline in concentration. As the disease progresses, memory problems worsen, communication skills decline, and individuals require more assistance with daily activities. In advanced stages, there is significant functional impairment and difficulty with communication and mobility.

Diagnosis challenges and screening recommendations

Diagnosing Alzheimer's disease in a person with Down syndrome is complex and relies on observing changes from an individual's baseline function, rather than standard cognitive tests.

  • Baseline assessment: Guidelines recommend documenting baseline abilities by age 35.
  • Caregiver input: Input from caregivers is crucial for identifying changes.
  • Specialized tools: Tools like the Dementia Scale for Down Syndrome (DSDS) exist.
  • Ruling out other conditions: It's important to exclude other medical issues common in Down syndrome that can mimic dementia symptoms.

Comparison of Alzheimer's disease in individuals with Down syndrome vs. general population

Feature Down Syndrome Associated Alzheimer's General Population (Late-Onset Alzheimer's)
Genetic Cause An extra copy of chromosome 21, including the APP gene. Multiple genetic and environmental factors; most common is APOE-ε4 allele.
Age of Onset Typically begins much earlier, with pathology starting around age 40 and symptoms in the mid-50s. Most commonly begins after age 65.
Initial Symptoms Often presents with behavioral and personality changes, or a loss of skills, before noticeable memory problems. Usually begins with difficulties remembering recent conversations or events.
Amyloid Plaque Buildup Accelerated accumulation of beta-amyloid plaques, starting decades earlier than symptom onset. Slower, more gradual accumulation over decades leading up to symptoms.
Rate of Progression Some studies suggest the disease may progress faster once symptoms begin. Can vary widely among individuals.

Conclusion

People with Down syndrome are at a significantly higher risk of developing Alzheimer's disease due to the triplication of the APP gene on chromosome 21. This leads to an earlier onset of brain pathology and symptoms. Diagnosis requires careful observation and caregiver input. While there is no cure, a healthy lifestyle and research offer hope for improved care and delayed onset. Research in this area provides valuable insights that may benefit the broader Alzheimer's community.

Authoritative Source Link

For more in-depth information and resources on the connection between Down syndrome and Alzheimer's, visit {Link: NDSS website https://ndss.org/resources/alzheimers}.

Frequently Asked Questions

While the brain pathology (amyloid plaques) begins around age 40, clinical symptoms of Alzheimer's usually appear in the mid-50s for people with Down syndrome.

The primary genetic reason is the extra copy of chromosome 21, which is characteristic of Down syndrome. This chromosome carries the APP gene, leading to an overproduction of the beta-amyloid protein that forms Alzheimer's-related plaques.

Yes, early symptoms often present as changes in personality and behavior, such as increased anxiety, irritability, or reduced interest in social activities, rather than memory loss being the first and most obvious symptom.

Diagnosis is made based on observing a decline from the individual's usual baseline functioning. It relies on caregiver reports, specialized cognitive assessments, and ruling out other medical conditions.

Currently, there is no known way to prevent the brain changes that occur. However, leading a healthy lifestyle that includes physical activity, good nutrition, and social engagement may help reduce risk or delay the onset of symptoms.

Researchers are studying biomarkers (such as in blood), brain scans, and potential drug treatments to better understand, track, and hopefully prevent the disease in individuals with Down syndrome. Studying this population offers unique insights for understanding Alzheimer's in the general population as well.

While the risk is extremely high, not every individual with Down syndrome will develop clinical symptoms of Alzheimer's disease in their lifetime. Research is ongoing to understand why some individuals remain asymptomatic despite having brain pathology.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.